- Home
- UVSP vs XERS Comparison
UVSP vs XERS Comparison
Compare UVSP & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UVSP
- XERS
- Stock Information
- Founded
- UVSP 1876
- XERS 2005
- Country
- UVSP United States
- XERS United States
- Employees
- UVSP N/A
- XERS N/A
- Industry
- UVSP Major Banks
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- UVSP Finance
- XERS Health Care
- Exchange
- UVSP Nasdaq
- XERS Nasdaq
- Market Cap
- UVSP 881.8M
- XERS 752.7M
- IPO Year
- UVSP 1989
- XERS 2018
- Fundamental
- Price
- UVSP $28.12
- XERS $5.38
- Analyst Decision
- UVSP Hold
- XERS Strong Buy
- Analyst Count
- UVSP 3
- XERS 6
- Target Price
- UVSP $29.00
- XERS $6.25
- AVG Volume (30 Days)
- UVSP 110.0K
- XERS 1.7M
- Earning Date
- UVSP 07-23-2025
- XERS 08-07-2025
- Dividend Yield
- UVSP 3.05%
- XERS N/A
- EPS Growth
- UVSP 12.34
- XERS N/A
- EPS
- UVSP 2.73
- XERS N/A
- Revenue
- UVSP $298,354,000.00
- XERS $222,551,000.00
- Revenue This Year
- UVSP $11.76
- XERS $35.31
- Revenue Next Year
- UVSP $4.25
- XERS $19.65
- P/E Ratio
- UVSP $10.57
- XERS N/A
- Revenue Growth
- UVSP 4.09
- XERS 29.88
- 52 Week Low
- UVSP $22.83
- XERS $2.10
- 52 Week High
- UVSP $32.86
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- UVSP 31.05
- XERS 62.75
- Support Level
- UVSP $29.10
- XERS $4.94
- Resistance Level
- UVSP $30.14
- XERS $5.22
- Average True Range (ATR)
- UVSP 0.88
- XERS 0.22
- MACD
- UVSP -0.42
- XERS -0.01
- Stochastic Oscillator
- UVSP 3.79
- XERS 86.44
About UVSP Univest Financial Corporation
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).